Elevation Oncology Cash Flow Statement

Financials in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	795	519	-120	602	1,016	Upgrade
Other Operating Activities	-731	-464	169	-556	-981	Upgrade
Operating Cash Flow	64	55	49	46	35	Upgrade
Operating Cash Flow Growth	16.36%	12.25%	6.52%	31.43%	-5.41%	Upgrade
Repurchase of Common Stock	-	-	-45	-4	-	Upgrade
Common Dividends Paid	-64	-55	-51	-46	-35	Upgrade
Other Financing Activities	-	-	40	10	-	Upgrade
Financing Cash Flow	-64	-55	-56	-40	-35	Upgrade
Net Cash Flow	-	-	-7	6	-	Upgrade
Levered Free Cash Flow	-	-	-	422.25	636	Upgrade
Unlevered Free Cash Flow	-	-	-	422.25	636	Upgrade
Change in Net Working Capital	-	-	-	-46	-1	Upgrade

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.